These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 24702978)
1. [Ceftaroline fosamil in community-acquired and nosocomial pneumonia]. Calbo E; Zaragoza R Enferm Infecc Microbiol Clin; 2014 Mar; 32 Suppl 2():38-43. PubMed ID: 24702978 [TBL] [Abstract][Full Text] [Related]
2. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Lodise TP; Low DE Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432 [TBL] [Abstract][Full Text] [Related]
3. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults. Welte T; Kantecki M; Stone GG; Hammond J Int J Antimicrob Agents; 2019 Oct; 54(4):410-422. PubMed ID: 31404620 [TBL] [Abstract][Full Text] [Related]
4. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. Low DE; File TM; Eckburg PB; Talbot GH; David Friedland H; Lee J; Llorens L; Critchley IA; Thye DA; J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii33-44. PubMed ID: 21482568 [TBL] [Abstract][Full Text] [Related]
5. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley IA; Thye DA; J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii19-32. PubMed ID: 21482566 [TBL] [Abstract][Full Text] [Related]
6. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Cannavino CR; Nemeth A; Korczowski B; Bradley JS; O'Neal T; Jandourek A; Friedland HD; Kaplan SL Pediatr Infect Dis J; 2016 Jul; 35(7):752-9. PubMed ID: 27093162 [TBL] [Abstract][Full Text] [Related]
7. Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia. Frampton JE Drugs; 2013 Jul; 73(10):1067-94. PubMed ID: 23801418 [TBL] [Abstract][Full Text] [Related]
8. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Jorgenson MR; DePestel DD; Carver PL Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993 [TBL] [Abstract][Full Text] [Related]
9. Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia. Scott LJ Drugs; 2016 Nov; 76(17):1659-1674. PubMed ID: 27766567 [TBL] [Abstract][Full Text] [Related]
12. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. DiMondi VP; Drew RH; Chen LF Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323 [TBL] [Abstract][Full Text] [Related]
14. [Zinforo™ (ceftaroline fosamil)--A new beta-lactam-cephalosporin with MRSA activity]. Welte T Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S89-90. PubMed ID: 25429539 [No Abstract] [Full Text] [Related]
15. Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA. Garrison MW; Kawamura NM; Wen MM Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1087-103. PubMed ID: 23167512 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis. Sotgiu G; Aliberti S; Gramegna A; Mantero M; Di Pasquale M; Trogu F; Saderi L; Blasi F Respir Res; 2018 Oct; 19(1):205. PubMed ID: 30352588 [TBL] [Abstract][Full Text] [Related]
17. Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Saravolatz LD; Stein GE; Johnson LB Clin Infect Dis; 2011 May; 52(9):1156-63. PubMed ID: 21467022 [TBL] [Abstract][Full Text] [Related]
18. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Torres A; Kuraieva A; Stone GG; Cillóniz C Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 37852658 [TBL] [Abstract][Full Text] [Related]
19. Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia. Rank DR; Friedland HD; Laudano JB J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii53-9. PubMed ID: 21482570 [TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients. Pasquale TR; Tan MJ; Trienski TL; File TM J Chemother; 2015 Feb; 27(1):29-34. PubMed ID: 24621164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]